NCT02465736 2024-01-16
Study of Docetaxel or Vinorelbine Plus Cisplatin in Neoadjuvant Chemoradiotherapy for Esophageal Cancer (NEOCRTEC308)
Sun Yat-sen University
Phase 3 Unknown
Clinical Trials
13 trialsNCT03790553 2023-08-03
Comparing 61.2 Gy Radiotherapy Dose Versus 50.4 Gy Radiotherapy Dose for Locally Advanced Esophageal Carcinoma
Fudan University
Phase 3 Unknown
NCT03958890 2023-04-18
A Clinical Trial Comparing HLX10 With Placebo Combined With Chemotherapy (Cisplatin + 5-fu) in the First-line Treatment of Locally Advanced/Metastatic Esophageal Squamous Cell Carcinoma (ESCC)
Shanghai Henlius Biotech
Phase 3 Unknown
NCT02025036 2023-02-08
CRTCOESC
The First Affiliated Hospital of Henan University of Science and Technology
Phase 3 Unknown
NCT03273647 2017-10-19
Adjuvant Radiotherapy for Esophageal Squamous Cell Carcinoma With Positive Circumstantial Resection Margin
Fudan University
Phase 3 Unknown
NCT01216527 2017-02-27
Phase III Study of Neo-adjuvant Chemoradiotherapy Followed by Surgery for Squamous Cell Esophageal Cancer
Sun Yat-sen University
Phase 3 Unknown
NCT02604615 2016-07-06
DCOECRT
The First Affiliated Hospital of Henan University of Science and Technology
Phase 3 Unknown
NCT02677597 2016-02-09
Cisplatin Combined With S-1 or Paclitaxel as First-line Treatment for Metastatic Esophageal Squamous Cell Carcinoma
Fudan University
Phase 3 Unknown
NCT02607540 2016-01-12
PFCRTESC
The First Affiliated Hospital of Henan University of Science and Technology
Phase 3 Unknown
NCT02628665 2015-12-11
Clinical Study of Time Optimizing of Endoscopic Photodynamic Therapy on Esophageal and/or Gastric Cardiac Cancer
The First Affiliated Hospital of Henan University of Science and Technology
Phase 3 Unknown
NCT02603159 2015-11-11
DCECRT
The First Affiliated Hospital of Henan University of Science and Technology
Phase 3 Unknown
NCT00002884 2013-08-07
Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus
National Cancer Institute (NCI)
Phase 3 Unknown
NCT01398449 2011-07-20
Is ENI Necessary For Patients With Thoracic Esophageal Cancer After Esophagectomy And With Pathological Stage Of T1-2,N+,M0
Fudan University
Phase 3 Unknown